Clin2
NCT06118463Possibly a fitNot yet recruiting

AUNIP as a new cervical cancer marker study

Cervical Cancer

Part of Cancer, Women’s health & pregnancy clinical trials.

This study is looking at a protein called AUNIP to see if it can be used as a new way to detect cervical cancer. If you have been diagnosed with cervical cancer, you may be able to help find if AUNIP levels in your body can signal the disease.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
20 years to 60 years
Study type
Observational

Who can take part

  • You are a woman between 20 and 60 years old
  • You have a confirmed diagnosis of cervical cancer
  • You do not have other tumors or lesions in the uterus or nearby areas

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07593066Not yet recruiting
Cervical cancer screening study for women

This study tests ways to improve cervical cancer screening for women ages 30–65. It may help catch cervical cancer early or prevent it entirely by finding precancerous changes.

Coyhaique, Aysén
NCT06866392Not yet recruiting
New cervical cancer screening with light and DNA test

This study is testing a new, non-invasive way to screen for cervical cancer. It uses a photoelectric device and an epigenetic test done on a sample from your cervix. The goal is to find early signs of cancer more accurately than current methods.

NCT04743674Recruiting
Blood and urine tests to track cervical cancer after treatment

This study tests whether DNA found in blood and urine can help detect cervical cancer and monitor it after treatment. If you’re newly diagnosed, these minimally invasive samples may help doctors follow your disease more easily over time.

Chapel Hill, North Carolina
NCT06304610Not yet recruiting
Validating a new tool to detect cervical precancer

This trial is testing a new screening tool (ELEVATE) to see how well it works in detecting cervical precancer. If you have an abnormal pap smear or a positive HPV test and are scheduled for a colposcopy, you may be able to help validate this tool.

Ghent, East-Flanders
NCT06042543Recruiting
Cervical cancer screening trial for unscreened women

This trial tests a new, affordable way to screen for cervical cancer that can be done in low- and middle-income countries. It uses artificial intelligence to help decide who needs follow-up care.

Cincinnati, Ohio
NCT05372484Recruiting
Test technology to improve cervical cancer screening and diagnosis

This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.

Houston, Texas

Hear when a new Cervical Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.